Morgan Stanley
- SEC CIK
- 0000895421
- Latest filing
- Aug 13, 2026
EDSA holding history
Edesa Biotech, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EDSA overviewAll 13F holders of EDSAFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,400
- Value
- $11.4K
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,400 | $11.4K | <0.1% | +1,400 | New | Holders |
| Q1 2026 | 0 | $0 | 0.0% | −2,300−100.0% | Sold out | Holders |
| Q4 2025 | 2,300 | $3.27K | <0.1% | +2,300 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −584−100.0% | Sold out | Holders |
| Q2 2025 | 584 | $1.19K | <0.1% | +584 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −14−100.0% | Sold out | Holders |
| Q4 2024 | 14 | $24 | <0.1% | −14−50.0% | Reduced | Holders |
| Q3 2024 | 28 | $125 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 28 | $120 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 28 | $117 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 28 | $128 | <0.1% | −1−2.0% | ReducedConverted for a 1-for-7 split | Holders |
| Q3 2023 | 200 | $126 | <0.1% | +200 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −1,371−100.0% | Sold out | Holders |
| Q4 2022 | 1,371 | $2.96K | <0.1% | +180+15.1% | Added | Holders |
| Q3 2022 | 1,191 | $1.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,191 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 1,191 | $4.00K | <0.1% | −274−18.7% | Reduced | Holders |
| Q4 2021 | 1,465 | $8.00K | <0.1% | +1,265+632.5% | Added | Holders |
| Q3 2021 | 200 | $1.00K | <0.1% | +200 | New | Holders |